May 1, 2013 - Update on CLL
- CLL signs and symptoms
- Tests used to diagnose and stage CLL
- Current and emerging treatments for CLL patients
- Personalized CLL treatment plans
- Importance of clinical trials to improve CLL patient outcomes
- CLL side effects management and quality of life
John C. Byrd, MD
D. Warren Brown Chair of Leukemia Research
Professor of Medicine, Medicinal Chemistry, and Veterinary Biosciences
Director, Division of Hematology, Department of Medicine
The Ohio State University
Questions Asked by the CLL Community
- Does spontaneous remission happen often?
- Is there a treatment in pill form that will soon be approved by the FDA and will this pill keep patients in remission?
- Are patients with CLL at higher risk of developing skin cancer than the general population?
- What is the actual life span of a CLL patient?
- Will there be any clinical trials for someone older, age 78, and in stage 4 CLL?
- Is there any news about the vaccine Genitope for CLL?
- You said lenalidomide (Revlimid®) is approved by NCCN. Is that different than when a drug is approved by the FDA?
- Are there any studies on milk thistle seed extract driving the white count down?
- Please address the clinical relevance of minimal residual disease (MRD) as it applies to CLL survivors and post-chemo follow-up monitoring and/or re-intervention.
- What is the preferred treatment for a senior who has had multiple therapies over the last four years?
- Given that CLL affects a patient's immune system, should a patient avoid taking any medications with a warning label stating that it may affect the immune system?
- Is a CLL patient's immune system compromised whether they are on treatment or not?
- Does having angioneurotic edema and ulcerative colitis affect a patient's CLL in any way?
- Does having high cholesterol have anything to do with CLL?
- Is CLL genetic? Can it be passed on to children?
- You talked about the drug ofatumumab. Is it the same as the drug Arzerra®?
- Do you have any recommendations on how to handle anxiety during watch and wait?
Sponsors and Supporters
This program is sponsored by The Leukemia & Lymphoma Society and supported by a grant from Teva Oncology.